P vivax management opd
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Here is a comprehensive summary of P. vivax OPD (outpatient) management from authoritative sources:
P. vivax — OPD Management
When is OPD appropriate?
Uncomplicated P. vivax can be managed outpatient. Hospital admission is not usually necessary unless:
- P. knowlesi is suspected (rapid progression risk)
- Signs of complicated/severe malaria are present (altered sensorium, severe anemia, respiratory distress, renal failure)
— Tintinalli's Emergency Medicine, p. 1103
Step 1 — Blood Schizonticide (Erythrocytic stage)
Chloroquine-sensitive areas (most regions except Indonesia, Solomon Islands, New Guinea, Brazil):
| Drug | Adult Dose |
|---|---|
| Chloroquine phosphate | 1 g, then 500 mg at 6 h, then 500 mg at 24 h and 48 h (total 2.5 g over 3 days) |
| Alternatively | 10 mg base/kg stat → 5 mg/kg at 12, 24, and 36 h |
Chloroquine-resistant P. vivax (Indonesia, Papua New Guinea, Solomon Islands, Brazil):
- Artemisinin-based combination therapy (ACT) — e.g., artemether-lumefantrine or artesunate-amodiaquine
- Alternatives: mefloquine ± artesunate, quinine, atovaquone-proguanil
— Goldman-Cecil Medicine; Harrison's 22E; Tintinalli's
Step 2 — Radical Cure (Liver hypnozoites — prevents relapse)
This is mandatory for P. vivax (unlike P. falciparum), as dormant hypnozoites in the liver cause relapses.
| Drug | Adult Dose | Notes |
|---|---|---|
| Primaquine phosphate | 30 mg base/day × 14 days | Most widely used |
| Primaquine (Southeast Asia / Oceania) | 0.5 mg/kg/day × 14 days | Higher dose for SE Asian strains |
| Tafenoquine (newer) | 300 mg single dose | Where available; requires normal G6PD |
| Primaquine (mild G6PD deficiency) | 0.75 mg/kg once weekly × 8 weeks | Slower regimen reduces hemolysis risk |
Critical: Check G6PD status before primaquine or tafenoquine. Both can cause life-threatening hemolysis in G6PD-deficient patients.
- G6PD severely deficient → do NOT give primaquine/tafenoquine; use chloroquine 300 mg base weekly for 6 months as suppressive therapy instead
- Pregnant patients → defer radical cure; use weekly chloroquine prophylaxis throughout pregnancy
— Goldman-Cecil Medicine p. ~1117; Harrison's 22E p. 1813; Tintinalli's p. 1103
Step 3 — Supportive Care
- Simple analgesia (paracetamol) for fever/headache
- Adequate oral hydration
- Monitor for complications (severe anemia, thrombocytopenia)
Exceptions — when primaquine is NOT needed:
- P. vivax acquired via needlestick, blood transfusion, or transplacental route (no hypnozoites formed)
- P. falciparum or P. malariae infections (no liver dormant stage)
Summary Table
| Component | Drug | Duration |
|---|---|---|
| Erythrocytic (blood) | Chloroquine 25 mg/kg total (3 days) | 3 days |
| Radical cure (liver) | Primaquine 30 mg base/day | 14 days |
| Alternative radical cure | Tafenoquine 300 mg | Single dose |
| Resistant vivax | ACT (e.g., artemether-lumefantrine) | 3 days |
Key takeaway: P. vivax OPD management = chloroquine (blood stage) + primaquine (liver stage), with G6PD testing mandatory before starting primaquine. Resistance areas require ACT in place of chloroquine.
This is a shared conversation. Sign in to Orris to start your own chat.